Vigil Net Receivables vs Property Plant Equipment Analysis

VIGL Stock

USD 3.05 0.01 0.33%

Vigil Neuroscience financial indicator trend analysis is much more than just breaking down Vigil Neuroscience prevalent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Vigil Neuroscience is a good investment. Please check the relationship between Vigil Neuroscience Net Receivables and its Property Plant Equipment accounts. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vigil Neuroscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

For more information on how to buy Vigil Stock please use our How to buy in Vigil Stock guide.

Net Receivables vs Property Plant Equipment

Net Receivables vs Property Plant Equipment Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Vigil Neuroscience Net Receivables account and Property Plant Equipment. At this time, the significance of the direction appears to have pay attention.

The correlation between Vigil Neuroscience's Net Receivables and Property Plant Equipment is -0.86. Overlapping area represents the amount of variation of Net Receivables that can explain the historical movement of Property Plant Equipment in the same time period over historical financial statements of Vigil Neuroscience, assuming nothing else is changed. The correlation between historical values of Vigil Neuroscience's Net Receivables and Property Plant Equipment is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Receivables of Vigil Neuroscience are associated (or correlated) with its Property Plant Equipment. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Property Plant Equipment has no effect on the direction of Net Receivables i.e., Vigil Neuroscience's Net Receivables and Property Plant Equipment go up and down completely randomly.

Correlation Coefficient

-0.86

Relationship Direction	Negative
Relationship Strength	Significant

View All Relationships

Net Receivables

Property Plant Equipment

Most indicators from Vigil Neuroscience's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Vigil Neuroscience current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vigil Neuroscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

For more information on how to buy Vigil Stock please use our How to buy in Vigil Stock guide.Enterprise Value is expected to rise to about 155.3 M this year, although the value of Selling General Administrative will most likely fall to about 17.3 M.

	2010	2022	2023	2024 (projected)
Interest Income	3K	623K	5.0M	5.2M
Net Interest Income	3K	623K	5.0M	5.2M

Interest Income Net Interest Income

Vigil Neuroscience fundamental ratios Correlations

	Total Assets	Short Long Term Debt Total	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Other Liab	Net Tangible Assets	Net Debt	Retained Earnings	Accounts Payable	Cash	Cash And Short Term Investments	Common Stock Shares Outstanding	Non Current Liabilities Total	Other Current Assets	Other Stockholder Equity	Total Liab	Net Invested Capital	Total Current Assets	Non Current Liabilities Other	Net Working Capital	Common Stock	Current Deferred Revenue	Non Currrent Assets Other	Other Assets	Deferred Long Term Liab
Total Assets		0.57	0.99	0.96	0.88	-0.51	0.84	-0.82	-0.86	0.65	0.92	1.0	0.02	-0.29	0.84	0.97	-0.19	0.88	1.0	-0.51	1.0	0.94	-0.51	-0.93	-0.91	-0.51
Short Long Term Debt Total	0.57		0.65	0.67	0.63	-0.95	0.82	0.0	-0.91	0.4	0.28	0.53	0.26	-0.4	0.04	0.69	-0.31	0.63	0.53	-0.95	0.51	0.66	-0.95	-0.67	-0.72	-0.95
Other Current Liab	0.99	0.65		0.97	0.9	-0.56	0.88	-0.75	-0.91	0.61	0.86	0.98	0.1	-0.34	0.77	1.0	-0.24	0.9	0.98	-0.56	0.97	0.95	-0.56	-0.95	-0.95	-0.56
Total Current Liabilities	0.96	0.67	0.97		0.76	-0.58	0.79	-0.7	-0.89	0.78	0.82	0.95	-0.12	-0.11	0.74	0.96	0.0	0.76	0.94	-0.58	0.94	0.99	-0.58	-0.85	-0.86	-0.58
Total Stockholder Equity	0.88	0.63	0.9	0.76		-0.6	0.96	-0.63	-0.85	0.24	0.77	0.88	0.46	-0.71	0.62	0.9	-0.63	1.0	0.87	-0.6	0.88	0.71	-0.6	-0.99	-0.96	-0.6
Other Liab	-0.51	-0.95	-0.56	-0.58	-0.6		-0.78	-0.02	0.84	-0.37	-0.3	-0.48	-0.2	0.41	-0.01	-0.58	0.33	-0.6	-0.48	1.0	-0.47	-0.54	1.0	0.61	0.62	1.0
Net Tangible Assets	0.84	0.82	0.88	0.79	0.96	-0.78		-0.46	-0.95	0.31	0.66	0.83	0.44	-0.68	0.46	0.9	-0.59	0.96	0.82	-0.78	0.82	0.74	-0.78	-0.96	-0.97	-0.78
Net Debt	-0.82	0.0	-0.75	-0.7	-0.63	-0.02	-0.46		0.41	-0.52	-0.95	-0.85	0.18	0.07	-1.0	-0.69	0.01	-0.63	-0.85	-0.02	-0.86	-0.67	-0.02	0.67	0.6	-0.02
Retained Earnings	-0.86	-0.91	-0.91	-0.89	-0.85	0.84	-0.95	0.41		-0.54	-0.63	-0.84	-0.22	0.43	-0.45	-0.93	0.33	-0.85	-0.83	0.84	-0.82	-0.87	0.84	0.9	0.93	0.84
Accounts Payable	0.65	0.4	0.61	0.78	0.24	-0.37	0.31	-0.52	-0.54		0.62	0.64	-0.7	0.49	0.58	0.57	0.58	0.24	0.64	-0.37	0.62	0.8	-0.37	-0.37	-0.36	-0.37
Cash	0.92	0.28	0.86	0.82	0.77	-0.3	0.66	-0.95	-0.63	0.62		0.94	-0.14	-0.18	0.95	0.81	-0.1	0.77	0.95	-0.3	0.95	0.78	-0.3	-0.81	-0.73	-0.3
Cash And Short Term Investments	1.0	0.53	0.98	0.95	0.88	-0.48	0.83	-0.85	-0.84	0.64	0.94		0.01	-0.29	0.86	0.96	-0.19	0.88	1.0	-0.48	1.0	0.92	-0.48	-0.93	-0.9	-0.48
Common Stock Shares Outstanding	0.02	0.26	0.1	-0.12	0.46	-0.2	0.44	0.18	-0.22	-0.7	-0.14	0.01		-0.92	-0.23	0.16	-0.94	0.46	0.0	-0.2	0.01	-0.16	-0.2	-0.36	-0.4	-0.2
Non Current Liabilities Total	-0.29	-0.4	-0.34	-0.11	-0.71	0.41	-0.68	0.07	0.43	0.49	-0.18	-0.29	-0.92		-0.02	-0.38	0.99	-0.71	-0.28	0.41	-0.29	-0.05	0.41	0.6	0.6	0.41
Other Current Assets	0.84	0.04	0.77	0.74	0.62	-0.01	0.46	-1.0	-0.45	0.58	0.95	0.86	-0.23	-0.02		0.71	0.04	0.62	0.87	-0.01	0.87	0.72	-0.01	-0.67	-0.61	-0.01
Other Stockholder Equity	0.97	0.69	1.0	0.96	0.9	-0.58	0.9	-0.69	-0.93	0.57	0.81	0.96	0.16	-0.38	0.71		-0.27	0.9	0.95	-0.58	0.95	0.94	-0.58	-0.96	-0.97	-0.58
Total Liab	-0.19	-0.31	-0.24	0.0	-0.63	0.33	-0.59	0.01	0.33	0.58	-0.1	-0.19	-0.94	0.99	0.04	-0.27		-0.63	-0.19	0.33	-0.2	0.06	0.33	0.52	0.51	0.33
Net Invested Capital	0.88	0.63	0.9	0.76	1.0	-0.6	0.96	-0.63	-0.85	0.24	0.77	0.88	0.46	-0.71	0.62	0.9	-0.63		0.87	-0.6	0.88	0.71	-0.6	-0.99	-0.96	-0.6
Total Current Assets	1.0	0.53	0.98	0.94	0.87	-0.48	0.82	-0.85	-0.83	0.64	0.95	1.0	0.0	-0.28	0.87	0.95	-0.19	0.87		-0.48	1.0	0.91	-0.48	-0.93	-0.89	-0.48
Non Current Liabilities Other	-0.51	-0.95	-0.56	-0.58	-0.6	1.0	-0.78	-0.02	0.84	-0.37	-0.3	-0.48	-0.2	0.41	-0.01	-0.58	0.33	-0.6	-0.48		-0.47	-0.54	1.0	0.61	0.62	1.0
Net Working Capital	1.0	0.51	0.97	0.94	0.88	-0.47	0.82	-0.86	-0.82	0.62	0.95	1.0	0.01	-0.29	0.87	0.95	-0.2	0.88	1.0	-0.47		0.9	-0.47	-0.93	-0.89	-0.47
Common Stock	0.94	0.66	0.95	0.99	0.71	-0.54	0.74	-0.67	-0.87	0.8	0.78	0.92	-0.16	-0.05	0.72	0.94	0.06	0.71	0.91	-0.54	0.9		-0.54	-0.81	-0.83	-0.54
Current Deferred Revenue	-0.51	-0.95	-0.56	-0.58	-0.6	1.0	-0.78	-0.02	0.84	-0.37	-0.3	-0.48	-0.2	0.41	-0.01	-0.58	0.33	-0.6	-0.48	1.0	-0.47	-0.54		0.61	0.62	1.0
Non Currrent Assets Other	-0.93	-0.67	-0.95	-0.85	-0.99	0.61	-0.96	0.67	0.9	-0.37	-0.81	-0.93	-0.36	0.6	-0.67	-0.96	0.52	-0.99	-0.93	0.61	-0.93	-0.81	0.61		0.99	0.61
Other Assets	-0.91	-0.72	-0.95	-0.86	-0.96	0.62	-0.97	0.6	0.93	-0.36	-0.73	-0.9	-0.4	0.6	-0.61	-0.97	0.51	-0.96	-0.89	0.62	-0.89	-0.83	0.62	0.99		0.62
Deferred Long Term Liab	-0.51	-0.95	-0.56	-0.58	-0.6	1.0	-0.78	-0.02	0.84	-0.37	-0.3	-0.48	-0.2	0.41	-0.01	-0.58	0.33	-0.6	-0.48	1.0	-0.47	-0.54	1.0	0.61	0.62

Click cells to compare fundamentals

Vigil Neuroscience Account Relationship Matchups

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Vigil Neuroscience is a strong investment it is important to analyze Vigil Neuroscience's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Vigil Neuroscience's future performance. For an informed investment choice regarding Vigil Stock, refer to the following important reports:

How To Invest In Vigil

Details

Is Vigil Stock a good investment?

Details

What is Vigil Neuroscience's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out World Market Map to better understand how to build diversified portfolios, which includes a position in Vigil Neuroscience. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in price.

For more information on how to buy Vigil Stock please use our How to buy in Vigil Stock guide.

You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Vigil Neuroscience. If investors know Vigil will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Vigil Neuroscience listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(2.07)

Return On Assets

(0.40)

Return On Equity

(0.70)

The market value of Vigil Neuroscience is measured differently than its book value, which is the value of Vigil that is recorded on the company's balance sheet. Investors also form their own opinion of Vigil Neuroscience's value that differs from its market value or its book value, called intrinsic value, which is Vigil Neuroscience's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Vigil Neuroscience's market value can be influenced by many factors that don't directly affect Vigil Neuroscience's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Vigil Neuroscience's value and its price as these two are different measures arrived at by different means. Investors typically determine if Vigil Neuroscience is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Vigil Neuroscience's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Vigil Net Receivables vs Property Plant Equipment Analysis

Net Receivables vs Property Plant Equipment

Net Receivables vs Property Plant Equipment Correlation Analysis

Correlation Coefficient

Net Receivables

Property Plant Equipment

Vigil Neuroscience fundamental ratios Correlations

Vigil Neuroscience Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Cash And Short Term Investments	+ 1.0	Total Assets
Total Current Assets	+ 1.0	Total Assets
Net Working Capital	+ 1.0	Total Assets
Other Stockholder Equity	+ 1.0	Other Current Liab
Net Invested Capital	+ 1.0	Total Stockholder Equity
Non Current Liabilities Other	+ 1.0	Other Liab

Other Current Assets	- 1.0	Net Debt
Non Currrent Assets Other	- 0.99	Net Invested Capital
Non Currrent Assets Other	- 0.99	Total Stockholder Equity
Other Assets	- 0.97	Other Stockholder Equity
Other Assets	- 0.97	Net Tangible Assets
Other Assets	- 0.96	Net Invested Capital